Why Invest in Elixinol Global Limited?
With more than 25 years’ experience in the hemp industry, Elixinol Global (ASX: EXL; OTC: ELLXF) is a trusted and established brand. Our fresh nutraceutical CBD offering and strong innovation pipeline reinforces our position as a global market leader in a high growth category.
According to the Brightfield Group, the US hemp derived CBD market reached $4.1b in sales in 2019 and forecasts a CAGR of 47% between 2019-2023. While in Europe the CBD market is expected to grow to nearly $1.6b by 2025, with a five-year CAGR of 46%.
As we continue to expand our global presence via dedicated sales teams in the US, UK, Europe and Australia, we are strongly positioned to take full advantage of the CBD market’s huge growth potential.